Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: Relationship to enteric hypersensitivity and dysmotility

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 11, 1998, Pages 1158-1163

  Evans, P R ^a   Piesse, C ^a   Bak, Y T ^a   Kellow, J E ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Fructose sorbitol; Irritable bowel syndrome; Jejunal motility; Symptoms; Visceral hyperalgesia

Indexed keywords

FRUCTOSE; HYDROGEN; LACTULOSE; SORBITOL;

ADULT; ARTICLE; CARBOHYDRATE INTOLERANCE; CLINICAL ARTICLE; COLON DILATATION; DIET RESTRICTION; FEMALE; FERMENTATION; HUMAN; HYDROGEN BREATH TEST; HYPERALGESIA; HYPERSENSITIVITY; INTESTINE DISTENSION; INTESTINE MOTILITY; IRRITABLE COLON; JEJUNUM; MANOMETRY; PRIORITY JOURNAL; PROVOCATION TEST; SYMPTOMATOLOGY;

EID: 0031744230     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850172502     Document Type: Article

References (21)

1. Mayer EA, Munakata J, Mertz H, Lembo T, Bernstein CN. Visceral hyperalgesia and irritable bowel syndrome. In: Gebhart GF, editor. Visceral pain, progress in pain research and management. Vol 5. Seattle (WA): IASP Press; 1995.
2. Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastro-intestinal disease is not site-specific. Dig Dis Sci 1995;40:1607-13.
3. Rumessen JJ, Gudmand-Høyer E. Malabsorption of fructose-sorbitol mixtures. Interactions causing abdominal distress. Scand J Gastroenterol 1987;22:431-6.
4. Rumessen JJ, Gudmand-Høyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol and fructose-sorbitol mixtures. Gastroenterology 1988; 95:694-700.
5. Talley NJ, Phillips SF, Melton JI, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-4.
6. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990;3: 159-72.
7. Saltzberg DM, Levine GM, Lubar C. Impact of age, sex, race and functional complaints on hydrogen (H 2) production. Dig Dis Sci 1988;33:308-13.
8. Fernandez-Bafiares F, Esteve-Pardo M, de Leon R, Humbert P, Cabré E, Llovet JM, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993; 88:2044-50.
9. Evans PR, Bak Y, Kellow JE. Ambulatory small bowel manometry in health - comparison of consecutive twenty-four hour recording periods. J Amb Monitoring 1996;9:193-202.
10. Evans PR, Bennett EJ, Bak Y-T, Tennant CC, Kellow JE. Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features. Gastroenterology 1996;110: 393-404.
11. Accarino AM, Azpiroz F, Malagelada J. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995;108:636-43.
12. Kotler DP, Holt PR, Rosenweig NS. Modification of the breath hydrogen test: increased sensitivity for the detection of carbohydrate malabsorption. J Lab Clin Med 1982;100:798-805.
13. Fritz Nelis G, Vermeeren MAP, Jansen WIM. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990;99:1016-20.
14. Kellow JE, Borody TJ, Phillips SF, Haddad AC, Brown ML. Sulfapyridine appearance in plasma after salicylazosulfapyridine. Gastroenterology 1986;91:396-400.
15. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973;14:125-32.
16. Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Dysmotility of the small intestine in irritable bowel syndrome. Gut 1988;29: 1236-43.
17. Prior A, Maxton DG, Whorwell PJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut 1990;31:458-62.
18. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, et al. Tolerance for rectosigmold distension in irritable bowel syndrome. Gastroenterology 1990;98:1187-92.
19. Hasler WL, Soudan HQ, Owyang C. Somatostatin analog inhibits afferent response to rectal distension in diarrhea-predominant irritable bowel patients. J Pharmacol Exp Ther 1994;268:1206-11.
20. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-93.
21. Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992;27:940-4.